Effect of weight reduction on insulin sensitivity, sex hormone-binding globulin, sex hormones and gonadotrophins in obese children

European Journal of Endocrinology

Volumn 163, Issue 6, 2010, Pages 895-900

  Birkebaek N H ^a   Lange, A ^a   Holland Fischer, P ^a   Kristensen, K ^a   Rittig, S ^a   Vilstrup, H ^a   Handberg, A ^a   Gronbaek, H ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; SEX HORMONE;

ADOLESCENT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CAUCASIAN; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; FEMALE; FOLLITROPIN BLOOD LEVEL; GENDER; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS GONAD SYSTEM; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MENARCHE; OBESITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBERTY; SCHOOL CHILD; SEX DIFFERENCE; TESTOSTERONE BLOOD LEVEL; VIRILIZATION; WEIGHT REDUCTION; BLOOD; GONADAL DISEASE; INSULIN RESISTANCE; METABOLISM; PHYSIOLOGY;

ADOLESCENT; CHILD; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; GONADAL STEROID HORMONES; GONADOTROPINS; HUMANS; INSULIN RESISTANCE; MALE; OBESITY; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; VIRILISM; WEIGHT LOSS;

EID: 78649821707     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0538     Document Type: Article

References (38)

1. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS & Caprio S. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. New England Journal of Medicine 2002 346 802-810. (doi:10.1056/NEJMoa012578) (Pubitemid 34984653)
2. O'Gorman DJ & Krook A. Exercise and the treatment of diabetes and obesity. Endocrinology and Metabolism Clinics of North America 2008 37 887-903. (doi:10.1016/j.ecl.2008.07.006)
3. Vitola BE, Deivanayagam S, Stein RI, Mohammed BS, Magkos F, Kirk EP & Klein S. Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents. Obesity 2009 17 1744-1748. (doi:10.1038/oby.2009.171)
4. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM & Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. New England Journal of Medicine 2009 361 1152-1163. (doi:10.1056/NEJMoa0804381)
5. Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J & Rissanen A. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes, Obesity and Metabolism 2004 6 208-215. (doi:10.1111/j.1462- 8902.2004.00335.x)
6. Golden SH, Dobs AS, Vaidya D, Szklo M, Gapstur S, Kopp P, Liu K & Ouyang P. Endogenous sex hormones and glucose tolerance status in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2007 92 1289-1295. (doi:10.1210/jc.2006-1895)
7. Colangelo LA, Ouyang P, Liu K, Kopp P, Golden SH, Dobs AS, Szklo M, Vaidya D, Cushman M & Gapstur SM. Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis. Diabetes Care 2009 32 1049-1051. (doi:10.2337/dc08-2216)
8. Gascon F, Valle M, Martos R, Ruz FJ, Rios R, Montilla P & Canete R. Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children. European Journal of Endocrinology 2000 143 85-89. (doi:10.1530/eje.0.1430085)
9. Galloway PJ, Donaldson MD & Wallace AM. Sex hormone binding globulin concentration as a prepubertal marker for hyperinsulinaemia in obesity. Archives of Disease in Childhood 2001 85 489-491. (doi:10.1136/adc.85.6.489)
10. Sorensen K, Aksglaede L, Munch-Andersen T, Aachmann- Andersen NJ, Petersen JH, Hilsted L, Helge JW & Juul A. Sex hormone-binding globulin levels predict insulin sensitivity, disposition index, and cardiovascular risk during puberty. Diabetes Care 2009 32 909-914. (doi:10.2337/dc08-1618)
11. Oya ID, Schoppen S, Lasuncion MA, Lopez-Simon L, Riestra P, Oya MD & Garces C. Sex hormone-binding globulin levels and metabolic syndrome and its features in adolescents. Pediatric Diabetes 2010 11 188-194. (doi:10.1111/j.1399-5448.2009.00559.x)
12. Agirbasli M, Agaoglu NB, Orak N, Caglioz H, Ocek T, Poci N, Salaj A & Maya S. Sex hormones and metabolic syndrome in children and adolescents. Metabolism 2009 58 1256-1262. (doi:10.1016/j.metabol.2009.03.024)
13. Mah PM & Wittert GA. Obesity and testicular function. Molecular and Cellular Endocrinology 2009 316 180-186. (doi:10.1016/j.mce.2009.06.007)
14. Nielsen TL, Hagen C, Wraae K, Brixen K, Petersen PH, Haug E, Larsen R & Andersen M. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. Journal of Clinical Endocrinology and Metabolism 2007 92 2696-2705. (doi:10.1210/jc.2006-1847)
15. Hauner H, Ditschuneit HH, Pal SB, Moncayo R & Pfeiffer EF. Fat distribution, endocrine and metabolic profile in obese women with and without hirsutism. Metabolism 1988 37 281-286. (doi:10.1016/0026-0495(88)90109-6)
16. Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D & Hayes FJ. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care 2005 28 1636-1642. (doi:10.2337/diacare.28.7.1636)
17. Oh JY, Barrett-Connor E, Wedick NM & Wingard DL. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care 2002 25 55-60. (doi:10.2337/diacare.25.1. 55)
18. Reinehr T, de SG, Roth CL & Andler W. Androgens before and after weight loss in obese children. Journal of Clinical Endocrinology and Metabolism 2005 90 5588-5595. (doi:10.1210/jc.2005-0438) (Pubitemid 41415463)
19. Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A & Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2004 89 5462-5468. (doi:10.1210/jc.2004-0804)
20. McCartney CR, Prendergast KA, Blank SK, Helm KD, Chhabra S & Marshall JC. Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls. Journal of Clinical Endocrinology and Metabolism 2009 94 56-66. (doi:10.1210/jc.2008-1252)
21. Wabitsch M, Hauner H, Heinze E, Bockmann A, Benz R, Mayer H & Teller W. Body fat distribution and steroid hormone concentrations in obese adolescent girls before and after weight reduction. Journal of Clinical Endocrinology and Metabolism 1995 80 3469-3475. (doi:10.1210/jc.80.12.3469)
22. Nysom K, Molgaard C, Hutchings B & Michaelsen KF. Body mass index of 0 to 45-y-old Danes: reference values and comparison with published European reference values. International Journal of Obesity and Related Metabolic Disorders 2001 25 177-184. (doi:10.1038/sj.ijo.0801515)
23. Marshall WA & Tanner JM. Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood 1969 44 291-303. (doi:10.1136/adc.44. 235.291)
24. Marshall WA & Tanner JM. Variations in the pattern of pubertal changes in boys. Archives of Disease in Childhood 1970 45 13-23. (doi:10.1136/adc.45.239.13)
25. Andersen L, Dinesen B, Jorgensen PN, Poulsen F & Roder ME. Enzyme immunoassay for intact human insulin in serum or plasma. Clinical Chemistry 1993 39 578-582.
26. Reinehr T, Kiess W, Kapellen T & Andler W. Insulin sensitivity among obese children and adolescents, according to degree of weight loss. Pediatrics 2004 114 1569-1573. (doi:10.1542/peds.2003-0649-F)
27. Ten S & Maclaren N. Insulin resistance syndrome in children. Journal of Clinical Endocrinology and Metabolism 2004 89 2526-2539. (doi:10.1210/jc. 2004-0276)
28. Viner RM, Segal TY, Lichtarowicz-Krynska E & Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Archives of Disease in Childhood 2005 90 10-14. (doi:10.1136/adc.2003.036467)
29. Rohrer TR, Rizzo VF, Cäsar JJ, Muelbredt O, Sprengart S, Gortner L & Stierkorb E. Changes in hepatic risk factors, metabolic variables, body composition, and physical fitness in obese children after a one-year weight loss program. Journal of Pediatric Endocrinology and Metabolism 2008 21 837-845.
30. Shalitin S, Ashkenazi-Hoffnung L, Yackobovitch-Gavan M, Nagelberg N, Karni Y, Hershkovitz E, Loewenthal N, Shtaif B, Gat-Yablonski G & Phillip M. Effects of a twelve-week randomized intervention of exercise and/or diet on weight loss and weight maintenance, and other metabolic parameters in obese preadolescent children. Hormone Research 2009 72 287-301. (doi:10.1159/ 000245931)
31. Eyzaguirre F & Mericq V. Insulin resistance markers in children. Hormone Research 2009 71 65-74. (doi:10.1159/000183894)
32. Diver MJ. Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men. Annals of Clinical Biochemistry 2006 43 3-12. (doi:10.1258/000456306775141803)
33. Giagulli VA, Kaufman JM & Vermeulen A. Pathogenesis of the decreased androgen levels in obese men. Journal of Clinical Endocrinology and Metabolism 1994 79 997-1000. (doi:10.1210/jc.79.4.997)
34. Sudi KM, Gallistl S, Borkenstein MH, Payerl D, Aigner R, Moller R & Tafeit E. Effects of weight loss on leptin, sex hormones, and measures of adiposity in obese children. Endocrine 2001 14 429-435. (doi:10.1385/ENDO:14:3: 429)
35. Reis LO, Favaro WJ, Barreiro GC, de Oliveira LC, Chaim EA, Fregonesi A & Ferreira U. Erectile dysfunction and hormonal imbalance in morbidly obese male is reversed after gastric bypass surgery: a prospective randomized controlled trial. International Journal of Andrology 2009 33 736-744. (doi:10.1111/j.1365-605.2009.01017.x)
36. Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S & Mohanty P. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Current Molecular Medicine 2008 8 816-828. (doi:10.2174/ 156652408786733658)
37. Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocrine Reviews 1991 12 3-13. (doi:10.1210/edrv-12- 1-3)
38. Nestler JE & Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. New England Journal of Medicine 1996 335 617-623. (doi:10.1056/NEJM199608293350902)